Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What’s The Deal With These Insiders Selling Shares?

Page 1 of 2

It is common knowledge that insider selling is quite problematic to interpret, as insiders tend to sell shares for various reasons that are not related to the future prospects of their companies. Therefore, we would not suggest you to act or trade immediately on each freshly-detected insider sale, but rather go for a more in-depth analysis of the companies that witness insider selling so as to clarify whether those insider trades are cause for concern. Thus, the analysis of insider selling should serve more as a tool in assessing the potential of a stock. The following article will discuss the insider selling activity at three companies and will also attempt to find out what might have propelled these companies’ insiders to sell stock. Let’s now see if the insider selling activity at these companies might hint at some good trading opportunities.

Facts, Myths, blackboard

Gustavo Frazao/

Prior to discussing the insider trading activity at those three companies, let’s make you familiar with what Insider Monkey has discovered. Through our research we discovered that a portfolio of the 15 most popular small-cap picks of an elite group of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith (and money) in large-cap stocks. In forward tests since August 2012 these top small-cap stocks beat the market by an impressive 53 percentage points, returning over 102% (read the details here). Follow the smart money into only their best investment ideas all while avoiding their high fees.

Moving on to the first company in question, Western Alliance Bancorporation (NYSE:WAL), two different insiders of the company sold stock this week. EVP and Chief Credit Officer Robert Reoch McAuslan sold 4,000 shares on Monday at a weighted average sale price of $34.54 and currently owns a stake of 39,229 shares. Similarly, Director Todd Marshall reported the selloff of a 28,471 share-stake on the same day at prices ranging from $34.52-to-$34.73, which was held by a trust fund called the Todd Marshall Revocable Family Trust. The Director continues to own a direct ownership stake of 51,846 shares, along with hundreds of thousands of shares owned indirectly through several trust funds. Western Alliance Bancorporation (NYSE:WAL)’s stock has gained nearly 23% year-to-date, mainly thanks to the company’s strong financial performance in the third quarter. The bank posted earnings per share of $0.58 on net operating revenue of $145.92 million, compared to EPS of $0.39 on revenue of $103.57 million reported a year ago. Therefore, the insiders’ moves provide evidence that insiders follow the stock market adage that says: “Buy on bad news, sell on good news”. Israel Englander’s Millennium Management is one of the hedge funds tracked by Insider Monkey that was bullish on Western Alliance Bancorporation (NYSE:WAL) at the end of the June quarter, owning 1.80 million shares.

Follow Western Alliance Bancorporation (NYSE:WAL)
Trade (NYSE:WAL) Now!

Let’s now turn the page, where we discuss the insider selling activity at two other companies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!